Soon-Shiong’s “Billion-Dollar Start-Up”: What’s He Building In There?
Patrick Soon-Shiong, MD, continues to reap financial rewards from his $2.9 billion sale of Abraxis Bioscience Inc. to Celgene Corp. in 2010. Some of the cash has gone famously to Soon-Shiong’s purchase of a slice of the Los Angeles Lakers basketball team, but much more of it has gone to his next big health care project, which he describes as his “billion-dollar start-up.”
You may also be interested in...
TransEnterix hires Shameze Rampertab as its new CFO and said it expects “modest growth” in Q3 and Q4.
Keeping Track: Viltepso Earns Priority Review Voucher; Manufacturing Trips Fennec; Eagle Drops Ryanodex Exertional Heat Stroke Bid
The latest drug development news and highlights from the Pink Sheet’s US FDA Performance Tracker.
CureVac raised hundreds of millions of dollars this year before its $213m initial public offering as its mRNA vaccine technology moved into the COVID-19 spotlight. Its stock price tripled on its debut.